The Centers for Disease Control and Prevention has released a framework for providing non-COVID-19 clinical care during the pandemic, based on the level of community transmission and potential for patient harm from deferring in-person care.

Among other considerations, CDC said health care systems should be prepared to rapidly detect and respond to an increase of COVID-19 cases in the community; provide care in the safest way possible; and consider that services may need to expand gradually. “Given the dynamic nature of the pandemic, considerations may change over time and vary by practice type and setting,” the agency notes.

The AHA, Association of periOperative Registered Nurses, American College of Surgeons and American Society of Anesthesiologists in April released a roadmap offering considerations for safely resuming elective surgery as the COVID-19 surge wanes in different parts of the country. Building on the April guidance, AHA, AORN and AdvaMed yesterday released clinically based guidance to support the safe reentry of medical device representatives into hospitals and other surgical facilities as they resume elective surgeries.

Related News Articles

Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…